Company Information
About the Report- Documents
Outstanding Payments (MSME)
Complaints
Directors- Same Address Companies
- Charges
Contact Details- Products & Services
Balance Sheet- Profit & Loss
Fund Raising- Shareholders & Investors
- Board Meetings
- Auditors
SYNGENE INTERNATIONAL LIMITED
CIN: L85110KA1993PLC014937
SYNGENE INTERNATIONAL LIMITED (CIN: L85110KA1993PLC014937) is a Public company incorporated on 18 Nov 1993. It is classified as Non-government company and is registered at Registrar of Companies, Bangalore. Its authorized share capital is Rs. 5000000000.00 and its paid up capital is Rs. 4036691470.00.
SYNGENE INTERNATIONAL LIMITED's Annual General Meeting (AGM) was last held on 26 Jul 2023. and as per records from Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 2023-03-31.SYNGENE INTERNATIONAL LIMITED's NIC code is 8511 (which is part of its CIN). As per the NIC code, it is inolved in Hospital activities.[Includes the activities of general and specialized hospitals, sanatoria, asylums, rehabilitation centres, dental centres and other health institutions that have accommodation facilities, including military base and prison hospitals]..
Directors of SYNGENE INTERNATIONAL LIMITED are VIJAY KUMAR KUCHROO, JONATHAN BRITTAN HUNT, KUSH M PARMAR, VINITA BALI, KIRAN MAZUMDAR SHAW, SHARMILA ABHAY KARVE, CATHERINE PATRICIA ROSENBERG, PAUL FREDRICK BLACKBURN, and NILANJAN ROY.
SYNGENE INTERNATIONAL LIMITED's Corporate Identification Number (CIN) is L85110KA1993PLC014937 and its registration number is 14937. Users may contact SYNGENE INTERNATIONAL LIMITED on its Email address - [email protected]. Registered address of SYNGENE INTERNATIONAL LIMITED is Biocon SEZ, Biocon Park,Plot.No.2 & 3, Bommasandra Indst. Area IV Phase, Jigani Link Rd, Bo mmasandra , Bangalore, Karnataka, India - 560099.
Current status of SYNGENE INTERNATIONAL LIMITED is - Active.
Basic Information
- CIN
- Name
- Listed on Stock Exchange
- Company Status
- ROC
- Registration Number
- Company Category
- Company Sub Category
- Class of Company
- Date of Incorporation
- Age of Company
- Activity
- Number of Members
Annual Compliance Status
- Date of Last Annual General Meeting
- Date of Last Filed Balance Sheet
Key Numbers
- Authorised Share Capital
- Paid-up Share Capital
- Total Assets
- Revenue
- Profit
- Salaries & Other Employee Benefit Expenses
Want to see how this company compares within its industry or analyse broader market trends?
Explore Prime Research for Industry & Economic InsightsPrevious Names
Previous CINs
ZaubaCorp's company report for SYNGENE INTERNATIONAL includes audited balance sheets, profit & loss statements, charges, director history, shareholding and related-party transactions, compiled from official MCA filings — delivered as PDF and Excel.
Purchase ReportAll companies in India are required to file various documents like financials, loan agreements, list of shareholders, details of directors, details of funding rounds and a lot more. These documents are credible and offer incredible insights about a company. However, understanding a company by viewing its documents is an extremely difficult and time consuming process.
Our reports are designed to save you significant time by surfacing key information easily and structuring it in a way that helps in your research.
Understanding the key findings and information in our reports can be crucial if you're a customer, vendor, investor, partner or even a potential employee of SYNGENE INTERNATIONAL
Purchase full report of SYNGENE INTERNATIONAL
Companies are required to file half yearly returns showing payments due to Micro & Small Enterprises that have been delayed more than 45 days. This information is crucial to understand if SYNGENE INTERNATIONAL pays its vendors promptly. When seen over a period of time, this information could show if the company has slowed down in making payments to its small vendors. This information is available only if the company has filed its half yearly returns with the registrar of companies.
| Filing Type | As On | Amount Due to MSME | Current Liabilities | Ratio to Current Liabilities | Reasons for Delay |
|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
This section contains details of investor complaints or serious complaints filed with the registrar of companies. This information can surface potential red flags about a company.
Director Complaints
| Date | DIN | Cessation Date | Cessation Reason | Complaint |
|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Serious Complaints
| Date | Complaint | Other Details |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
Investor Complaints & Other Complaints
| Date | Complaint Type | Complaint Sub Type | Particulars of Secutiries | Period | Complaint | Other Details |
|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current Directors & Key Managerial Personnel of SYNGENE INTERNATIONAL
| DIN | Director Name | Designation | Appointment Date |
|---|---|---|---|
| 07071727 | VIJAY KUMAR KUCHROO | Director | 2017-07-28 |
| 07774619 | JONATHAN BRITTAN HUNT | Managing Director | 2020-04-01 |
| 09212020 | KUSH M PARMAR | Director | 2021-07-21 |
| 00032940 | VINITA BALI | Director | 2018-07-25 |
| 00347229 | KIRAN MAZUMDAR SHAW | Director | 2020-07-22 |
| 05018751 | SHARMILA ABHAY KARVE | Director | 2020-07-22 |
| 06422834 | CATHERINE PATRICIA ROSENBERG | Director | 2000-08-08 |
| 06958360 | PAUL FREDRICK BLACKBURN | Director | 2014-09-11 |
| 02703775 | NILANJAN ROY | Director | 2024-04-30 |
Past Directors & Key Managerial Personnel of SYNGENE INTERNATIONAL
| DIN | Director Name | Designation | Appointment Date | Cessation |
|---|---|---|---|---|
| 06959449 | SIBAJI BISWAS | Additional Director | - | 2024-06-09 |
| 06959449 | SIBAJI BISWAS | CFO | - | 2024-11-30 |
| 06959449 | SIBAJI BISWAS | Director | - | 2024-11-30 |
| 07071727 | VIJAY KUMAR KUCHROO | Additional Director | - | 2017-07-28 |
| 07774619 | JONATHAN BRITTAN HUNT | Additional Director | - | 2017-05-01 |
| 07774619 | JONATHAN BRITTAN HUNT | Whole-time director | - | 2020-04-01 |
| 09212020 | KUSH M PARMAR | Additional Director | - | 2021-07-21 |
| 00032940 | VINITA BALI | Additional Director | - | 2018-07-25 |
| 00347229 | KIRAN MAZUMDAR SHAW | Additional Director | - | 2020-07-22 |
| 00347229 | KIRAN MAZUMDAR SHAW | Director | - | 2011-12-14 |
| 00347229 | KIRAN MAZUMDAR SHAW | Managing Director | - | 2020-03-31 |
| 00430937 | PETER JOHN BAINS | Director | - | 2017-04-27 |
| 00430937 | PETER JOHN BAINS | Whole-time director | - | 2016-03-31 |
| 01553650 | CHINAPPA MUCKATIRA BHEMAIAH | CFO(KMP) | - | 2019-12-17 |
| 06599933 | DANIEL MARK BRADBURY | Additional Director | - | 2013-07-24 |
| 06599933 | DANIEL MARK BRADBURY | Director | - | 2016-05-15 |
| 01327667 | BALA S MANIAN | Additional Director | - | 2016-06-30 |
| 01327667 | BALA S MANIAN | Director | - | 2020-07-15 |
| 00001456 | SURESH NARSAPPA TALWAR | Additional Director | - | 2016-06-30 |
| 00001456 | SURESH NARSAPPA TALWAR | Director | - | 2019-07-24 |
| 01056607 | CHARLES LELAND COONEY | Director | - | 2015-06-22 |
| 05018751 | SHARMILA ABHAY KARVE | Additional Director | - | 2020-07-22 |
| 06958360 | PAUL FREDRICK BLACKBURN | Additional Director | - | 2014-09-11 |
| 08576667 | CARL DECICCO PETER | Additional Director | - | 2022-05-30 |
| 08576667 | CARL DECICCO PETER | Director | - | 2022-02-28 |
| 00347250 | JOHN MCCALLUM MARSHALL SHAW | Director | - | 2021-07-21 |
| 02703775 | NILANJAN ROY | Additional Director | - | 2024-06-09 |
| 03528496 | JOHN RUSSELL FOTHERINGHAM WALLS | Additional Director | - | 2011-07-20 |
| 03528496 | JOHN RUSSELL FOTHERINGHAM WALLS | Director | - | 2019-07-24 |
Other Directorships of SIBAJI BISWAS
Other Directorships of VIJAY KUMAR KUCHROO
| Company Name | CIN | Designation | Appointment Date | Cessation |
|---|---|---|---|---|
| BIOCON LIMITED | L24234KA1978PLC003417 | Additional Director | - | 2015-07-24 |
| BIOCON LIMITED | L24234KA1978PLC003417 | Director | - | 2018-07-26 |
| BIOCON PHARMA LIMITED | U24232KA2014PLC077036 | Additional Director | - | 2017-07-28 |
| BIOCON PHARMA LIMITED | U24232KA2014PLC077036 | Director | - | 2017-10-26 |
Other Directorships of JONATHAN BRITTAN HUNT
| Company Name | CIN | Designation | Appointment Date | Cessation |
|---|
Other Directorships of KUSH M PARMAR
| Company Name | CIN | Designation | Appointment Date | Cessation |
|---|
Other Directorships of VINITA BALI
Other Directorships of KIRAN MAZUMDAR SHAW
Other Directorships of PETER JOHN BAINS
| Company Name | CIN | Designation | Appointment Date | Cessation |
|---|---|---|---|---|
| BIOCON LIMITED | L24234KA1978PLC003417 | Additional Director | - | 2023-03-13 |
| BIOCON LIMITED | L24234KA1978PLC003417 | Director | - | 2023-09-18 |
| GLAXOSMITHKLINE PHARMACEUTICALS LIMITED | L24239MH1924PLC001151 | Director | - | 2009-07-27 |
| FERMENTA BIOTECH LIMITED | U99999MH1986PLC134021 | Additional Director | - | 2010-09-27 |
| FERMENTA BIOTECH LIMITED | U99999MH1986PLC134021 | Director | - | 2018-03-30 |
Other Directorships of CHINAPPA MUCKATIRA BHEMAIAH
| Company Name | CIN | Designation | Appointment Date | Cessation |
|---|---|---|---|---|
| BIOCON BIOLOGICS LIMITED | U24119KA2016PLC093936 | CFO | - | 2023-10-31 |
| BIOCON BIOPHARMACEUTICALS LIMITED | U24231KA2002PLC030643 | Alternate Director | 2007-03-22 | Ongoing |
| CLINIGENE INTERNATIONAL LIMITED | U85195KA2000PLC027566 | Additional Director | - | 2013-07-24 |
| CLINIGENE INTERNATIONAL LIMITED | U85195KA2000PLC027566 | Director | 2013-07-24 | Ongoing |
Other Directorships of DANIEL MARK BRADBURY
| Company Name | CIN | Designation | Appointment Date | Cessation |
|---|---|---|---|---|
| BIOCON LIMITED | L24234KA1978PLC003417 | Additional Director | - | 2013-07-26 |
| BIOCON LIMITED | L24234KA1978PLC003417 | Director | - | 2022-07-27 |
| BIOCON BIOLOGICS LIMITED | U24119KA2016PLC093936 | Additional Director | - | 2020-07-24 |
| BIOCON BIOLOGICS LIMITED | U24119KA2016PLC093936 | Director | 2020-07-24 | Ongoing |
| BIOCON RESEARCH LIMITED | U73100KA2008PLC046583 | Additional Director | - | 2015-07-24 |
| BIOCON RESEARCH LIMITED | U73100KA2008PLC046583 | Director | - | 2017-10-26 |
Other Directorships of BALA S MANIAN
| Company Name | CIN | Designation | Appointment Date | Cessation |
|---|---|---|---|---|
| BIOCON LIMITED | L24234KA1978PLC003417 | Director | - | 2015-07-24 |
| REAMETRIX INDIA PRIVATE LIMITED | U73100KA2002PTC030005 | Director | 2004-03-04 | Ongoing |
Other Directorships of SURESH NARSAPPA TALWAR
Other Directorships of CHARLES LELAND COONEY
| Company Name | CIN | Designation | Appointment Date | Cessation |
|---|---|---|---|---|
| BIOCON LIMITED | L24234KA1978PLC003417 | Director | - | 2015-07-24 |
| MITRA BIOTECH PRIVATE LIMITED | U73100KA2009PTC051875 | Director | - | 2016-12-19 |
Other Directorships of SHARMILA ABHAY KARVE
Other Directorships of CATHERINE PATRICIA ROSENBERG
| Company Name | CIN | Designation | Appointment Date | Cessation |
|---|
Other Directorships of PAUL FREDRICK BLACKBURN
| Company Name | CIN | Designation | Appointment Date | Cessation |
|---|
Other Directorships of CARL DECICCO PETER
| Company Name | CIN | Designation | Appointment Date | Cessation |
|---|
Other Directorships of JOHN MCCALLUM MARSHALL SHAW
| Company Name | CIN | Designation | Appointment Date | Cessation |
|---|---|---|---|---|
| - | 2023-04-25 | |||
| BIOCON LIMITED | L24234KA1978PLC003417 | Director | - | 2021-07-23 |
| BIOCON LIMITED | L24234KA1978PLC003417 | Whole-time director | - | 2017-07-01 |
| BIOCON BIOPHARMACEUTICALS LIMITED | U24231KA2002PLC030643 | Director | 2002-06-17 | Ongoing |
| BIOCON PHARMA LIMITED | U24232KA2014PLC077036 | Director | - | 2022-07-31 |
| BIOCON BIOSPHERE LIMITED | U24304KA2019PLC130965 | Director | - | 2022-07-31 |
| GLENLOCH PROPERTIES PRIVATE LIMITED | U70200KA2010PTC052807 | Director | - | 2017-02-06 |
| BIOCON RESEARCH LIMITED | U73100KA2008PLC046583 | Director | 2008-05-28 | Ongoing |
| BIOFUSION THERAPEUTICS LIMITED | U73100KA2021PLC145487 | Director | - | 2022-07-31 |
| BIOCON ACADEMY | U80301KA2013NPL072272 | Director | - | 2022-07-31 |
| MAZUMDAR SHAW MEDICAL FOUNDATION | U84120KA2013NPL069050 | Additional Director | - | 2014-11-08 |
| MAZUMDAR SHAW MEDICAL FOUNDATION | U84120KA2013NPL069050 | Director | - | 2022-10-24 |
| CLINIGENE INTERNATIONAL LIMITED | U85195KA2000PLC027566 | Director | 2000-08-04 | Ongoing |
Other Directorships of NILANJAN ROY
Other Directorships of JOHN RUSSELL FOTHERINGHAM WALLS
| CIN | Company Name | Company Address |
|---|
| Charge ID | Charge Creation Date | Charge Modification Date | Charge Closure Date | Assets Under Charge | Amount | Charge Holder |
|---|---|---|---|---|---|---|
| 10019838 | 2006-08-30 | - | 2009-04-22 | 150,000,000.00 | CITIBANK NA | |
| 10101396 | 2008-03-19 | 2008-09-25 | 2016-01-29 | 500,000,000.00 | ABN Amro Bank N. V. | |
| 10108590 | 2008-02-28 | - | 2014-11-13 | 800,000,000.00 | State Bank of India | |
| 10129679 | 2008-09-27 | - | 2011-04-20 | 100,000,000.00 | STATE BANK OF INDIA | |
| 10274310 | 2011-02-28 | 2012-04-26 | 2016-08-08 | 500,000,000.00 | THE BANK OF NOVA SCOTIA | |
| 90196748 | 1994-07-29 | 2010-08-20 | 2022-09-20 | 1,636,500,000.00 | THE HONGKONG AND SHANGHAI BANKING CORPORATION LIMITED | |
| 90196794 | 1994-12-29 | 1995-05-17 | 2000-03-13 | 350,000.00 | ICICI BANKING CORPORATION LTD | |
| 100051271 | 2016-09-15 | 2017-02-28 | 2022-05-18 | 6,700,000,000.00 | The Hongkong and Shanghai Banking Corporation Limited | |
| 100439676 | 2021-03-30 | - | - | 3,750,000,000.00 | KOTAK MAHINDRA BANK LIMITED | |
| 100471904 | 2021-08-03 | - | 2023-11-10 | 3,700,251,300.00 | Mizuho Bank Limited |
- Email ID
- Website
- Address
This information shows products and services that contribute highest to the company's revenue. Analysing this over a period of time can show the evolution of the company in terms of the products and services it offers.
| Financial Year | Business Activity Code | Business Activity Description | Percentage of Turnover |
|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
Financial information is availalbe only if it has been filed by the company. If the company has not filed its returns, financials for the defaulting period will not be available.
| 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 | 2018-03-31 | 2017-03-31 | 2016-03-31 | 2015-03-31 | 2014-03-31 | 2013-03-31 | 2012-03-31 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Download Audited Financials | |||||||||||||
| EQUITY AND LIABILITIES | |||||||||||||
| Shareholder's funds | |||||||||||||
| Share Capital |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Reserves & Surplus |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Money Received Against Share Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share Application Money Pending Allotment |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Non-current Liabilities | |||||||||||||
| Long-term borrowings |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Deferred tax liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other Long Term Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Long Term Provisions |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Current Liabilities | |||||||||||||
| Short-term borrowings |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Trade Payables |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other Current Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Short Term Provisions |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total Equity and Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
| ASSETS | |||||||||||||
| Non-current Assets | |||||||||||||
| Fixed Assets | |||||||||||||
| Tangible Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Intangible Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital Work In Progress |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Intangible Assets Under Development |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Non-current Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Deferred Tax Assets (net) |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Long-term Loans & Advances |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other Non-current Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Current Assets | |||||||||||||
| Current Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Inventories |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Trade receivables |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cash & Cash Equivalents |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Short-term Loans & Advances |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other Current Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial information is availalbe only if it has been filed by the company. If the company has not filed its returns, financials for the defaulting period will not be available.
| 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 | 2018-03-31 | 2017-03-31 | 2016-03-31 | 2015-03-31 | 2014-03-31 | 2013-03-31 | 2012-03-31 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Download Audited Financials | |||||||||||||
| REVENUE FROM OPERATIONS | |||||||||||||
| Domestic Turnover | |||||||||||||
| Sale of Goods Manufactured |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale of Goods Traded |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale of Supple of Services |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Export Turnover | |||||||||||||
| Sale of Goods Manufactured |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale of Goods Traded |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale or Supply of Services |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other Income |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total Revenue From Operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
| EXPENSES | |||||||||||||
| Cost of Materials Consumed |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchases of Stock in Trade |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Change in Inventories of |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Finished Goods |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Work in Progress |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock in Trade |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Employee benefit Expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Managerial Remuneration |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Payment to Auditors |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Insurance Expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Power & Fuel |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Finance Cost |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Depreciation & Amortization Expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other Expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total Expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Profit before Exceptional Items, Extraordinary Items and Tax |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exceptional Items |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Profit before Extraordinary items and Tax |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Extraordinary Items |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Profit before Tax |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tax Expense | |||||||||||||
| Current Tax |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Deferred Tax |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Profit/Loss after Tax from Continuing Operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Profit/Loss after Tax from Discontinuing Operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tax Expense of Discontinuing Operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total Profit/Loss |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Earnings per Equity Share (EPS) before Extraordinary Items |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Basic |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Diluted |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Earnings per Equity Share (EPS) after Extraordinary Items |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Basic |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Diluted |
|
|
|
|
|
|
|
|
|
|
|
|
|
This section contains details of cash raised by allocation of equity or debentures. All types of fund raising acitivity is listed here including funding raised through Venture Capital. Attachments would contain further details of the fund raising activity including names of the investors. This information is available only if the company has raised funds through cash allotment of equity or debentures.
| Date of Allotment | Securities Alloted | Terms | Number of Securities | Nominal Amount | Premium Amount Due & Payable | Premium Amount Paid | Total Discount | Amount to be Paid on Calls (Excluding Premium) | Attachments |
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
This section contains list of associate companies and joint ventures as per the most recently available annual returns. This information would not be available if the company has not filed annual returns at all or it does not have any subsidiaries or joint ventures.
| Company Identifier | Name | Percentage of Shares Held |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
This section contains list of board resolutions reported by the company to the Registrar of Companies.
| Date of Filing | Date of Dispatch of Notice | Date of Passing Resolution | Section (Companies Act 2013) | Section (Companies Act 1956) | Subject Matter of Resolution | Resolution Agreed By | Resolution Type | Additional Documents |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
This section contains auditors of a company over the years. This information is available if the company has filed their annual returns with the Registrar of Companies.
| Financial Year | Name of Auditor or Firm | PAN of Auditor or Firm | Membership Number / Registration Number | Name of Auditor Signing Report | Membership Number of Auditor Signing Report |
|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As on: 2026-07-13
Is this information out of date or is there a discrepancy with the information? Click on the Update Information button below and we will review the information.